{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T01:24:53Z","timestamp":1776302693795,"version":"3.50.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1C1C1005930"],"award-info":[{"award-number":["2021R1C1C1005930"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Korea government"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,28]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>This study aims to investigate the potential correlation between the hematological dose (HEDOS), representing the dynamic blood dose, and severe radiation-induced lymphopenia (SRIL). The study examines whether SRIL mediates the relationship between HEDOS and oncologic outcomes in patients with hepatocellular carcinoma (HCC). A total of 41 patients with HCC who received radiation therapy to the liver and\/or perihepatic metastatic lesions were retrospectively analyzed. Blood-related organs (spleen, heart, veins, aortas, lungs, and liver) were manually delineated. HEDOS was calculated using a Markov chain model. The effective dose to immune cells (EDIC), representing the static blood dose, was calculated for comparison with HEDOS. We examined whether these two blood dose metrics correlated with SRIL, defined as an absolute lymphocyte count below 500\/\u03bcL one month after radiotherapy. The association between blood dose metrics and clinical outcomes, local and distant recurrence-free survival (LFS and DFS) was also evaluated. The mean HEDOS was significantly associated with SRIL, with an odds ratio of 1.61 (95% confidence interval [CI]: 1.10\u20132.54, P\u2009=\u20090.02). The mean HEDOS was associated with worse LFS and DFS, with hazard ratios of 1.35 (95% CI: 1.06\u20131.71, P\u2009=\u20090.01) for LFS and 1.28 (95% CI: 1.01\u20131.63, P\u2009=\u20090.04) for DFS. No association was observed between EDIC and any of the outcomes. A higher mean HEDOS showed a statistically significant correlation with SRIL and clinical outcomes, whereas the EDIC did not. The HEDOS, which incorporates temporal delivery characteristics such as dose rate and beam-on-time, may have an advantage for predicting SRIL and clinical outcomes of patients with HCC.<\/jats:p>","DOI":"10.1093\/jrr\/rraf087","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T13:14:34Z","timestamp":1765458874000},"page":"148-157","source":"Crossref","is-referenced-by-count":1,"title":["Blood dose estimates in radiotherapy and correlations with adverse clinical outcomes in hepatocellular carcinoma"],"prefix":"10.1093","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0810-1298","authenticated-orcid":false,"given":"Sangseok","family":"Ha","sequence":"first","affiliation":[{"name":"Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea , 222, Banpo-Daero, Seocho-gu, Seoul, 06591 ,","place":["Republic of Korea"]},{"name":"Department of Medical Sciences, Graduate School of The Catholic University of Korea , 222, Banpo-Daero, Seocho-gu, Seoul, 06591 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4723-3931","authenticated-orcid":false,"given":"Tae Hoon","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine , 81, Irwon-ro, Seoul, 06351 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2027-7472","authenticated-orcid":false,"given":"Eui Kyu","family":"Chie","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine , 101, Daehak-ro, Jongno-gu, Seoul, 03080 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0235-9979","authenticated-orcid":false,"given":"Jaeman","family":"Son","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine , 101, Daehak-ro, Jongno-gu, Seoul, 03080 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0449-1372","authenticated-orcid":false,"given":"Chang Heon","family":"Choi","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine , 101, Daehak-ro, Jongno-gu, Seoul, 03080 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8981-6123","authenticated-orcid":false,"given":"Hyun-Cheol","family":"Kang","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Seoul National University Hospital, Seoul National University College of Medicine , 101, Daehak-ro, Jongno-gu, Seoul, 03080 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-0646","authenticated-orcid":false,"given":"Wonmo","family":"Sung","sequence":"additional","affiliation":[{"name":"Department of Biomedical Engineering, College of Medicine, The Catholic University of Korea , 222, Banpo-Daero, Seocho-gu, Seoul, 06591 ,","place":["Republic of Korea"]},{"name":"Department of Medical Sciences, Graduate School of The Catholic University of Korea , 222, Banpo-Daero, Seocho-gu, Seoul, 06591 ,","place":["Republic of Korea"]},{"name":"CMC Institute for Basic Medical Science, the Catholic Medical Center of The Catholic University of Korea , 222, Banpo-Daero, Seocho-gu, Seoul, 06591 ,","place":["Republic of Korea"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"2026013002570958700_ref1","doi-asserted-by":"publisher","first-page":"330","DOI":"10.4143\/crt.2022.128","article-title":"Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2019","volume":"54","author":"Kang","year":"2022","journal-title":"Cancer Res Treat"},{"key":"2026013002570958700_ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026013002570958700_ref3","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3348\/kjr.2022.0822","article-title":"2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma","volume":"23","author":"Korean Liver Cancer Association, National Cancer Center Korea","year":"2022","journal-title":"Korean J Radiol"},{"key":"2026013002570958700_ref4","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.semradonc.2018.06.007","article-title":"Radiation-induced liver disease and modern radiotherapy","volume":"28","author":"Koay","year":"2018","journal-title":"Semin Radiat Oncol"},{"key":"2026013002570958700_ref5","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.jhep.2020.09.026","article-title":"Proton beam radiotherapy vs. Radiofrequency ablation for recurrent hepatocellular carcinoma: a randomized phase III trial","volume":"74","author":"Kim","year":"2021","journal-title":"J Hepatol"},{"key":"2026013002570958700_ref6","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1001\/jamaoncol.2017.5847","article-title":"Efficacy and safety of transarterial chemoembolization plus external beam radiotherapy vs sorafenib in hepatocellular carcinoma with macroscopic vascular invasion: a randomized clinical trial","volume":"4","author":"Yoon","year":"2018","journal-title":"JAMA oncology"},{"key":"2026013002570958700_ref7","first-page":"223\u201332","article-title":"Assessment of DNA damage and chromosome aberration in human lymphocyte exposed to low dose radiation detected by FISH (fluorescence in situ hybridization) and SCGE (single cell gel electrophoresis)","volume":"25","author":"Chung","year":"2000","journal-title":"J Korean Assoc Radiat Prot"},{"key":"2026013002570958700_ref8","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.radonc.2022.01.003","article-title":"The impact of radiation induced lymphopenia in the prognosis of head and neck cancer: a systematic review and meta-analysis","volume":"168","author":"Dai","year":"2022","journal-title":"Radiother Oncol"},{"key":"2026013002570958700_ref9","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1016\/j.ijrobp.2021.07.1695","article-title":"The influence of severe radiation-induced lymphopenia on overall survival in solid tumors: a systematic review and meta-analysis","volume":"111","author":"Damen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026013002570958700_ref10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.critrevonc.2018.01.003","article-title":"A systematic review of the influence of radiation-induced lymphopenia on survival outcomes in solid tumors","volume":"123","author":"Venkatesulu","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"2026013002570958700_ref11","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1007\/s00066-019-01462-5","article-title":"Acute severe lymphopenia by radiotherapy is associated with reduced overall survival in hepatocellular carcinoma","volume":"195","author":"Byun","year":"2019","journal-title":"Strahlenther Onkol"},{"key":"2026013002570958700_ref12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2147\/JHC.S282062","article-title":"Radiation-associated lymphopenia and outcomes of patients with unresectable hepatocellular carcinoma treated with radiotherapy","volume":"8","author":"De","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"2026013002570958700_ref13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.3389\/fonc.2019.00896","article-title":"Association between circulating lymphocyte populations and outcome after stereotactic body radiation therapy in patients with hepatocellular carcinoma. Front","volume":"9","author":"Zhuang","year":"2019","journal-title":"Oncol"},{"key":"2026013002570958700_ref14","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"2026013002570958700_ref15","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1016\/j.ijrobp.2021.11.008","article-title":"Mathematical modeling to simulate the effect of adding radiation therapy to immunotherapy and application to hepatocellular carcinoma","volume":"112","author":"Sung","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026013002570958700_ref16","doi-asserted-by":"publisher","first-page":"100391","DOI":"10.1016\/j.jtocrr.2022.100391","article-title":"Severe radiation-induced lymphopenia attenuates the benefit of durvalumab after concurrent chemoradiotherapy for NSCLC","volume":"3","author":"Jing","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"2026013002570958700_ref17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.radonc.2020.07.025","article-title":"A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy","volume":"151","author":"Sung","year":"2020","journal-title":"Radiother Oncol"},{"key":"2026013002570958700_ref18","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ijrobp.2025.03.082","article-title":"Spatial dose-response pattern associated with severe radiation-induced Lymphopenia in the liver: a voxel-based analysis","volume":"123","author":"Kim","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026013002570958700_ref19","doi-asserted-by":"publisher","first-page":"164001","DOI":"10.1088\/1361-6560\/ac16ea","article-title":"HEDOS\u2014A computational tool to assess radiation dose to circulating blood cells during external beam radiotherapy based on whole-body blood flow simulations","volume":"66","author":"Shin","year":"2021","journal-title":"Phys Med Biol"},{"key":"2026013002570958700_ref20","doi-asserted-by":"publisher","first-page":"110030","DOI":"10.1016\/j.radonc.2023.110030","article-title":"The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC","volume":"190","author":"Friedes","year":"2024","journal-title":"Radiother Oncol"},{"key":"2026013002570958700_ref21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.radonc.2020.02.015","article-title":"The impact of the effective dose to immune cells on lymphopenia and survival of esophageal cancer after chemoradiotherapy","volume":"146","author":"Xu","year":"2020","journal-title":"Radiother Oncol"},{"key":"2026013002570958700_ref22","doi-asserted-by":"publisher","first-page":"109934","DOI":"10.1016\/j.radonc.2023.109934","article-title":"Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy","volume":"189","author":"Yang","year":"2023","journal-title":"Radiother Oncol"},{"key":"2026013002570958700_ref23","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13014-018-0952-y","article-title":"Modelling the immunosuppressive effect of liver SBRT by simulating the dose to circulating lymphocytes: an in-silico planning study","volume":"13","author":"Basler","year":"2018","journal-title":"Radiat Oncol"},{"key":"2026013002570958700_ref24","doi-asserted-by":"publisher","first-page":"6485","DOI":"10.1002\/mp.17181","article-title":"Predicting radiation-induced immune suppression in lung cancer patients treated with stereotactic body radiation therapy","volume":"51","author":"Colen","year":"2024","journal-title":"Med Phys"},{"key":"2026013002570958700_ref25","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.radonc.2019.11.014","article-title":"A framework for modeling radiation induced lymphopenia in radiotherapy","volume":"144","author":"Jin","year":"2020","journal-title":"Radiother Oncol"},{"key":"2026013002570958700_ref26","doi-asserted-by":"publisher","first-page":"045010","DOI":"10.1088\/1361-6560\/ac4da4","article-title":"A dynamic blood flow model to compute absorbed dose to circulating blood and lymphocytes in liver external beam radiotherapy","volume":"67","author":"Xing","year":"2022","journal-title":"Phys Med Biol"},{"key":"2026013002570958700_ref27","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3109\/07357907.2012.762780","article-title":"The etiology of treatment-related lymphopenia in patients with malignant gliomas: modeling radiation dose to circulating lymphocytes explains clinical observations and suggests methods of modifying the impact of radiation on immune cells","volume":"31","author":"Yovino","year":"2013","journal-title":"Cancer Investig"},{"key":"2026013002570958700_ref28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0146-6453(03)00002-2","article-title":"Basic anatomical and physiological data for use in radiological protection: reference values: ICRP publication 89: approved by the Commission in September 2001","volume":"32","author":"Valentin","year":"2002","journal-title":"Ann ICRP"},{"key":"2026013002570958700_ref29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.prro.2013.06.004","article-title":"Upper abdominal normal organ contouring guidelines and atlas: a radiation therapy oncology group consensus","volume":"4","author":"Jabbour","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"2026013002570958700_ref30","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.ijrobp.2023.11.060","article-title":"Normal tissue complication probability modeling of severe radiation-induced lymphopenia using blood dose for patients with hepatocellular carcinoma","volume":"119","author":"Kim","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026013002570958700_ref31","doi-asserted-by":"publisher","first-page":"1119173","DOI":"10.3389\/fonc.2023.1119173","article-title":"Reduced radiation exposure to circulating blood cells in proton therapy compared with X-ray therapy in locally advanced lung cancer: computational simulation based on circulating blood cells","volume":"13","author":"Kim","year":"2023","journal-title":"Front Oncol"},{"key":"2026013002570958700_ref32","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1016\/j.ijrobp.2023.01.054","article-title":"Predicting severity of radiation induced lymphopenia in individual proton therapy patients for varying dose rate and fractionation using dynamic 4-dimensional blood flow simulations","volume":"116","author":"McCullum","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026013002570958700_ref33","doi-asserted-by":"publisher","first-page":"928119","DOI":"10.3389\/fonc.2022.928119","article-title":"Trends in radiotherapy administration in the management of hepatocellular carcinoma: analysis of a Korean tertiary hospital registry of hepatocellular carcinoma patients diagnosed between 2005 and 2017","volume":"12","author":"Bae","year":"2022","journal-title":"Front Oncol"},{"key":"2026013002570958700_ref34","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/s41571-021-00573-2","article-title":"Immunotherapies for hepatocellular carcinoma","volume":"19","author":"Llovet","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"2026013002570958700_ref35","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1007\/s00066-024-02240-8","article-title":"Determinants of radiation dose to immune cells during breast radiotherapy","volume":"201","author":"Loap","year":"2025","journal-title":"Strahlenther Onkol"},{"key":"2026013002570958700_ref36","doi-asserted-by":"publisher","first-page":"1066255","DOI":"10.3389\/fimmu.2023.1066255","article-title":"Higher radiation dose on immune cells is associated with radiation-induced lymphopenia and worse prognosis in patients with locally advanced esophageal squamous cell carcinoma","volume":"14","author":"Qiu","year":"2023","journal-title":"Front Immunol"},{"key":"2026013002570958700_ref37","doi-asserted-by":"publisher","first-page":"105009","DOI":"10.1088\/1361-6560\/ad3c8d","article-title":"LymphoDose: a lymphocyte dose estimation framework\u2014application to brain radiotherapy","volume":"69","author":"Kermenguy","year":"2024","journal-title":"Phys Med Biol"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/1\/148\/66398609\/rraf087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/67\/1\/148\/66398609\/rraf087.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T07:57:12Z","timestamp":1769759832000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/67\/1\/148\/8424666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,13]]},"published-print":{"date-parts":[[2026,1,28]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rraf087","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]}}}